We tested whether MALAT1 expression and NR4A1-downstream RE accessibility were strongly correlated in cancer types, such as BRCA (Figure 4C), versus low- or no-correlation cancers, such as pancreatic adenocarcinoma (PDAC) (Figure 5A). The gene discussed is NR4A1; the disease is pancreatic adenocarcinoma.